Pemetrexed in the firs line chemotherapy of malignant pleuralmesotelioma. A multicentre prospective study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00052781" target="_blank" >RIV/00216224:14110/11:00052781 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Pemetrexed in the firs line chemotherapy of malignant pleuralmesotelioma. A multicentre prospective study
Original language description
Malignant pleural mesothelioma (MPM) is a tumour with extremely unfavourable prognosis. Early diagnostic is rarely possible and chemotherapy has only a limited value in prolongation of survival. During the last years pemetrexed became the standard 1st line chemotherapy.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů